pros and cons of glp-1 weight loss medications have significant side effects The new generation of weight
Description
The study included 67,841 patients taking semaglutide (75.6%), 15,661 taking tirzepatide (17.5%), and 6,216 taking liraglutide (6.9%)
Coverage is not guaranteed and depends on your specific plans formulary, prior authorization criteria, and medical necessity requirements
Ozempic, like Wegovy, uses the active ingredient semaglutide
Exercise considerations Exercise benefits both drug classes but requires different precautions
